Literature DB >> 19224408

Pure red-cell aplasia as the presenting feature of the carcionoid tumor of the thymus: case report.

S M Petakov1, N Suvajdzić, D M Petakov, D Sefer, S Ognjanović, D Macut, M Durović, T Isailović, D Subotić, J Stojsić, V Todorović, S Damjanović.   

Abstract

Acquired pure red-cell aplasia (PRCA) is an uncommon disorder of erythrocytopoiesis that can develop in association with thymic tumors. We present the very rare case of a severely anemic 62-year-old man with PRCA and a concurrent neuroendocrine carcinoid tumor of the thymus. The anterior mediastinal thymus tumor was completely excised, and following histological and immunohistochemical analyses (showing positive staining for cytokeratin, chromogranin A, synaptophysin, and neuron-specific enolase) the diagnosis of a (grade I; T(1)N(0)M(0)) typical carcinoid tumor of the thymus was made. Postoperatively the anemia persisted despite no signs of residual tumor on CT chest. A hematological work up found: normocellularity with <0.5% erythroblasts and preserved megakaryocytopoiesis and granulocytopoiesis in a trephine biopsy; reduced numbers of Colony Forming Unit Erythroid (CFU-E) and normal numbers of Burst-Forming Unit Erythroid (BFU-E) in bone marrow colony-forming assays; a markedly increased level of serum erythropoietin; normal T and B-cell numbers with a normal CD4/CD8 ratio; and no clonal T-cell receptor -gamma and -delta gene rearrangement) The patient responded favorably to a therapeutic trial of glucocorticoid immunosuppressive treatment (prednisone 1 mg/kg/day) with a normalization of the reticulocyte count and hematocrit, suggesting an immunologic mechanism for the PRCA. Though the exact mechanisms underlying the association between the PRCA and the carcinoid tumor of the thymus remain unknown.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224408     DOI: 10.1007/s12032-009-9175-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  10 in total

Review 1.  Pure red cell aplasia.

Authors:  P Fisch; R Handgretinger; H E Schaefer
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

2.  Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience.

Authors:  Carrie A Thompson; David P Steensma
Journal:  Br J Haematol       Date:  2006-11       Impact factor: 6.998

Review 3.  The biology of pure red cell aplasia.

Authors:  E N Dessypris
Journal:  Semin Hematol       Date:  1991-10       Impact factor: 3.851

4.  Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients.

Authors:  D A Clark; E N Dessypris; S B Krantz
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

Review 5.  Pure red-cell aplasia: a review.

Authors:  A J Erslev; A Soltan
Journal:  Blood Rev       Date:  1996-03       Impact factor: 8.250

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  New Insights into the Pathophysiology of Acquired Cytopenias.

Authors:  Neal S. Young; Janis L. Abkowitz; Lucio Luzzatto
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2000

Review 8.  Acquired pure red cell aplasia in Japan.

Authors:  S Mamiya; T Itoh; A B Miura
Journal:  Eur J Haematol       Date:  1997-10       Impact factor: 2.997

9.  Th1/Th2 balance alteration in the clinical course of a patient with pure red cell aplasia and thymoma.

Authors:  S Fujisao; H Tsuda
Journal:  Br J Haematol       Date:  1998-11       Impact factor: 6.998

10.  A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus.

Authors:  Olivier Tiffet; Andrew G Nicholson; Georges Ladas; Mary N Sheppard; Peter Goldstraw
Journal:  Chest       Date:  2003-07       Impact factor: 9.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.